The term GGTase-Iβ Activators refers to chemical compounds that can indirectly influence the activity of the enzyme Geranylgeranyltransferase type I beta subunit (GGTase-Iβ). This enzyme plays a crucial role in the post-translational modification of proteins through a process known as prenylation, where it adds geranylgeranyl groups to certain proteins, enabling their anchoring to cell membranes and participation in various cellular processes. The compounds that can serve as indirect activators of GGTase-Iβ largely fall into two categories: those that are involved in the production of the enzyme's substrates, and those that influence the enzyme's metabolic pathway. Compounds like Geranylgeraniol, Isopentenyl pyrophosphate (IPP), and Dimethylallyl pyrophosphate (DMAPP) are precursors to the formation of geranylgeranyl pyrophosphate, the primary substrate for GGTase-Iβ. An increase in the availability of these precursors can indirectly enhance the enzymatic activity of GGTase-Iβ. On the other hand, compounds like Mevalonic acid, Farnesyl pyrophosphate, and Geranyl pyrophosphate are involved in the mevalonate pathway, which leads to the synthesis of geranylgeranyl pyrophosphate. An increase in the presence of these compounds can also indirectly influence the function of GGTase-Iβ.
Interestingly, the activity of GGTase-Iβ can also be indirectly influenced by certain compounds that regulate the mevalonate pathway, such as Lovastatin, Simvastatin, Pravastatin, Atorvastatin, and Rosuvastatin. These compounds inhibit the mevalonate pathway, potentially affecting the availability of geranylgeranyl pyrophosphate, and hence, the activity of GGTase-Iβ. However, their influence on the enzyme is indirect and complex. In summary, GGTase-Iβ Activators comprise a diverse collection of compounds that can indirectly influence the activity of GGTase-Iβ by modulating the availability of its substrates or the pathways related to its function. While these compounds do not directly trigger the activation of GGTase-Iβ, their ability to impact the enzyme's function indirectly provides valuable insights into the regulation of this important post-translational modification process.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geranylgeraniol | 24034-73-9 | sc-200858 sc-200858A | 20 mg 100 mg | $159.00 $465.00 | 14 | |
Geranylgeraniol is a precursor of geranylgeranyl pyrophosphate, the substrate used by GGTase-Iβ in the geranylgeranylation of proteins. Increasing the availability of this precursor can indirectly enhance the activity of GGTase-Iβ. | ||||||
Farnesyl pyrophosphate ammonium salt | 13058-04-3 | sc-200847 sc-200847A | 1 mg 5 mg | $469.00 $1938.00 | ||
Farnesyl pyrophosphate is a precursor of geranylgeranyl pyrophosphate. Its presence can indirectly influence GGTase-Iβ. | ||||||
Geranylgeranylpyrophosphate triammonium salt | 6699-20-3 | sc-200849 | 200 µg | $120.00 | ||
Geranyl pyrophosphate is an intermediate in the synthesis of geranylgeranyl pyrophosphate, and can indirectly influence GGTase-Iβ. | ||||||
Squalene | 111-02-4 | sc-281155 sc-281155A sc-281155B | 10 ml 100 ml 500 ml | $48.00 $90.00 $211.00 | 1 | |
Squalene is a downstream product of the mevalonate pathway, and its presence might reflect the availability of intermediates for geranylgeranyl pyrophosphate synthesis. | ||||||
Cholesterol | 57-88-5 | sc-202539C sc-202539E sc-202539A sc-202539B sc-202539D sc-202539 | 5 g 5 kg 100 g 250 g 1 kg 25 g | $26.00 $2754.00 $126.00 $206.00 $572.00 $86.00 | 11 | |
Cholesterol is a downstream product of the mevalonate pathway, and its presence might reflect the availability of intermediates for geranylgeranyl pyrophosphate synthesis. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
Lovastatin can inhibit the mevalonate pathway, potentially affecting the availability of geranylgeranyl pyrophosphate. However, its effects on GGTase-Iβ would be indirect and complex. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Simvastatin can inhibit the mevalonate pathway, potentially affecting the availability of geranylgeranyl pyrophosphate. However, its effects on GGTase-Iβ would be indirect and complex. | ||||||
Pravastatin | 81093-37-0 | sc-222188 | 50 mg | $400.00 | 1 | |
Pravastatin can inhibit the mevalonate pathway, potentially affecting the availability of geranylgeranyl pyrophosphate. However, its effects on GGTase-Iβ would be indirect and complex. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Atorvastatin can inhibit the mevalonate pathway, potentially affecting the availability of geranylgeranyl pyrophosphate. However, its effects on GGTase-Iβ would be indirect and complex. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $142.00 | 8 | |
Rosuvastatin can inhibit the mevalonate pathway, potentially affecting the availability of geranylgeranyl pyrophosphate. However, its effects on GGTase-Iβ would be indirect and complex. | ||||||